A detailed history of Ci Private Wealth, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Ci Private Wealth, LLC holds 21,855 shares of AUPH stock, worth $177,462. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,855
Previous 23,105 5.41%
Holding current value
$177,462
Previous $131,000 22.14%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$5.32 - $7.33 $6,650 - $9,162
-1,250 Reduced 5.41%
21,855 $160,000
Q2 2024

Aug 13, 2024

SELL
$4.81 - $5.78 $1,202 - $1,445
-250 Reduced 1.07%
23,105 $131,000
Q1 2024

May 09, 2024

SELL
$4.93 - $9.31 $5,423 - $10,241
-1,100 Reduced 4.5%
23,355 $117,000
Q4 2023

Feb 09, 2024

SELL
$7.13 - $9.49 $66,066 - $87,934
-9,266 Reduced 27.48%
24,455 $219,000
Q3 2023

Nov 03, 2023

BUY
$7.77 - $12.27 $262,012 - $413,756
33,721 New
33,721 $262,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.